Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32161
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Thompson, Daryl | - |
dc.contributor.author | Bensley, Jonathan G | - |
dc.contributor.author | Tempo, Jake | - |
dc.contributor.author | Ehdaie, Behfar | - |
dc.contributor.author | Carlsson, Sigrid | - |
dc.contributor.author | Eastham, James | - |
dc.contributor.author | Bolton, Damien M | - |
dc.contributor.author | Perera, Marlon | - |
dc.contributor.author | Papa, Nathan | - |
dc.date | 2022 | - |
dc.date.accessioned | 2023-02-14T04:27:47Z | - |
dc.date.available | 2023-02-14T04:27:47Z | - |
dc.date.issued | 2023-02 | - |
dc.identifier.citation | European Urology Oncology 2023; 6(1) | en_US |
dc.identifier.issn | 2588-9311 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/32161 | - |
dc.description.abstract | Active surveillance (AS) represents the preferred treatment option in patients with low-risk prostate cancer. Optimised patient selection has enabled more patients to be managed with AS for a longer time. Thus, there is growing interest in its effect on long-term quality of life compared with interventional management. | en_US |
dc.language.iso | eng | - |
dc.subject | Active surveillance | en_US |
dc.subject | Prostate cancer | en_US |
dc.subject | Quality of life | en_US |
dc.subject | Sexual function | en_US |
dc.subject | Systematic review | en_US |
dc.subject | Urinary function | en_US |
dc.title | Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic Review. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | European Urology Oncology | en_US |
dc.identifier.affiliation | Surgery (University of Melbourne) | en_US |
dc.identifier.affiliation | School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. | en_US |
dc.identifier.affiliation | Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. | en_US |
dc.identifier.doi | 10.1016/j.euo.2022.09.001 | en_US |
dc.type.content | Text | en_US |
dc.identifier.pubmedid | 36156268 | - |
dc.description.volume | 6 | - |
dc.description.issue | 1 | - |
dc.description.startpage | 4 | - |
dc.description.endpage | 15 | - |
dc.subject.meshtermssecondary | Prostatic Neoplasms/surgery | - |
local.name.researcher | Bolton, Damien M | |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | Urology | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Urology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.